Is there a "curative" role of radiotherapy for clinically localized hormone refractory prostate cancer?

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 27, Issue 3, 2004, Pages 264-268

  Sanguineti, Giuseppe ^a   Marcenaro, Michela ^a   Franzone, Paola ^a   Tognoni, Piero ^b   Barra, Salvina ^a   Vitale, Vito ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Androgen deprivation; Hormone refractory prostate cancer; Radiotherapy

Indexed keywords

ANTIANDROGEN; GONADORELIN; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; HUMAN; MALE; METASTASIS; PHYSICAL EXAMINATION; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROSTATECTOMY; RADIATION INJURY; RECTUM HEMORRHAGE; RETROSPECTIVE STUDY; TRANSRECTAL ULTRASONOGRAPHY; TRANSURETHRAL RESECTION; UROGENITAL TRACT DISEASE;

AGED; AGED, 80 AND OVER; ANDROGEN ANTAGONISTS; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PALLIATIVE CARE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 2942530301     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.coc.0000092565.46506.bc     Document Type: Article

References (16)

1. Fowler FJ Jr, McNaughton Collins M, Albertsen PC, et al. Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer. JAMA. 2000;283:3217-3222.
2. Sandblom G, Dufmats M, Nordenskjold K, et al. Prostate carcinoma trends in three counties in Sweden 1987-1996: results from a population-based national cancer register. South-East Region Prostate Cancer Group. Cancer. 2000;88:1445-1453.
3. Wasson JH, Fowler FJ Jr, Barry MJ. Androgen deprivation therapy for asymptomatic advanced prostate cancer in the prostate specific antigen era: a national survey of urologist beliefs and practices. J Urol. 1998;159:1993-1996.
4. Leibowitz RL, Tucker SJ. Treatment of localized prostate cancer with intermittent triple androgen blockade: preliminary results in 110 consecutive patients. Oncologist. 2001;6:177-182.
5. Labrie F, Cusan L, Gomez JL, et al. Long-term combined androgen blockade alone for localized prostate cancer. Mol Urol. 1999;3:217-226.
6. Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council Trial. The Medical Research Council Prostate Cancer Working Party Investigators Group. Br J Urol. 1997;79:235-246.
7. Fowler JE Jr, Bigler SA, White PC, et al. Hormone therapy for locally advanced prostate cancer. J Urol. 2002;168:546-549.
8. Kwak C, Jeong SJ, Park MS, et al. Prognostic significance of the nadir prostate specific antigen level after hormone therapy for prostate cancer. J Urol. 2002;168:995-1000.
9. Akaza H, Homma Y, Okada K, et al. Early results of LH-RH agonist treatment with or without chlormadinone acetate for hormone therapy of naive localized or locally advanced prostate cancer: a prospective and randomized study. The Prostate Cancer Study Group. Jpn J Clin Oncol. 2000;30:131-136.
10. Lankford SP, Pollack A, Zagars GK. Radiotherapy for regionally localized hormone refractory prostate cancer. Int J Radiat Oncol Biol Phys. 1995;33:907-912.
11. Sanguineti G, Franzone P, Marcenaro M, et al. Androgen deprivation impacts late rectal toxicity after conformal radiotherapy. Abstract 1328. In: Proceedings of 36th Annual ASCO Meeting, New Orleans, LA, May 20-23, 2000: p 338a.
12. Sanguineti G, Marcenaro M, Franzone P, et al. Radiotherapy for prostate-confined hormone refractory prostate cancer. Int J Radiat Oncol Biol Phys. 2001;51:280.
13. Sanguineti G, Agostinelli S, Foppiano F, et al. Adjuvant androgen deprivation impacts late rectal toxicity after conformal radiotherapy of prostate carcinoma. Br J Cancer. 2002;86:1843-1847.
14. Consensus statement: guidelines for PSA following radiation therapy. American Society for Therapeutic Radiology and Oncology Consensus Panel. Int J Radiat Oncol Biol Phys. 1997;37:1035-1041.
15. Furuya Y, Akakura K, Akimoto S, et al. Radiotherapy for local progression in patients with hormone-refractory prostate cancer. Int J Urol. 1999;6:187-191.
16. Newling DW, Denis L, Vermeylen K. Orchiectomy versus goserelin and flutamide in the treatment of newly diagnosed metastatic prostate cancer. Analysis of the criteria of evaluation used in the European Organization for Research and Treatment of Cancer-Genitourinary Group Study 30853. Cancer. 1993;72(12 suppl):3793-3798.